vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $23.6M, roughly 1.3× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -32.1%, a 46.7% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
GENC vs LFCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $31.1M |
| Net Profit | $3.4M | $-10.0M |
| Gross Margin | 28.7% | 25.0% |
| Operating Margin | 13.2% | -9.9% |
| Net Margin | 14.6% | -32.1% |
| Revenue YoY | -25.0% | -4.5% |
| Net Profit YoY | -9.8% | -52.0% |
| EPS (diluted) | $0.23 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | — | ||
| Q3 25 | $18.8M | $31.1M | ||
| Q2 25 | $27.0M | — | ||
| Q1 25 | $38.2M | $35.2M | ||
| Q4 24 | $31.4M | $32.6M | ||
| Q3 24 | $20.9M | $24.7M | ||
| Q2 24 | $25.6M | — | ||
| Q1 24 | $40.7M | $35.7M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | $1.9M | $-10.0M | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $6.1M | $-14.8M | ||
| Q4 24 | $3.8M | $-6.6M | ||
| Q3 24 | $1.5M | $-16.2M | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $6.2M | $15.6M |
| Q4 25 | 28.7% | — | ||
| Q3 25 | 24.2% | 25.0% | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 29.7% | 28.0% | ||
| Q4 24 | 27.6% | 34.0% | ||
| Q3 24 | 25.6% | 21.8% | ||
| Q2 24 | 23.9% | — | ||
| Q1 24 | 30.3% | 33.3% |
| Q4 25 | 13.2% | — | ||
| Q3 25 | -1.2% | -9.9% | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 17.0% | -25.7% | ||
| Q4 24 | 14.7% | -6.0% | ||
| Q3 24 | 5.9% | -46.9% | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 17.4% | -2.5% |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 10.2% | -32.1% | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 16.0% | -42.0% | ||
| Q4 24 | 12.1% | -20.2% | ||
| Q3 24 | 6.9% | -65.7% | ||
| Q2 24 | 10.0% | — | ||
| Q1 24 | 15.3% | 43.8% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.13 | $-0.29 | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.42 | $-0.47 | ||
| Q4 24 | $0.26 | $-0.25 | ||
| Q3 24 | $0.10 | $-0.53 | ||
| Q2 24 | $0.17 | — | ||
| Q1 24 | $0.42 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $215.2M | $-10.5M |
| Total Assets | $228.9M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | — | ||
| Q3 25 | $136.3M | $18.9M | ||
| Q2 25 | $136.0M | — | ||
| Q1 25 | $143.7M | $5.4M | ||
| Q4 24 | $130.1M | $9.5M | ||
| Q3 24 | $115.4M | — | ||
| Q2 24 | $116.6M | — | ||
| Q1 24 | $117.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $0 | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | $0 | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $215.2M | — | ||
| Q3 25 | $211.8M | $-10.5M | ||
| Q2 25 | $209.9M | — | ||
| Q1 25 | $206.1M | $2.2M | ||
| Q4 24 | $200.0M | $15.4M | ||
| Q3 24 | $196.1M | $-3.9M | ||
| Q2 24 | $194.7M | — | ||
| Q1 24 | $192.1M | $17.7M |
| Q4 25 | $228.9M | — | ||
| Q3 25 | $222.6M | $235.2M | ||
| Q2 25 | $220.2M | — | ||
| Q1 25 | $223.9M | $237.7M | ||
| Q4 24 | $218.2M | $255.4M | ||
| Q3 24 | $208.1M | $246.8M | ||
| Q2 24 | $201.8M | — | ||
| Q1 24 | $206.0M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $1.8M |
| Free Cash FlowOCF − Capex | $10.1M | $25.0K |
| FCF MarginFCF / Revenue | 43.0% | 0.1% |
| Capex IntensityCapex / Revenue | 4.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | — | ||
| Q3 25 | $-275.0K | $1.8M | ||
| Q2 25 | $-23.9M | — | ||
| Q1 25 | $12.4M | $1.2M | ||
| Q4 24 | $14.8M | $-6.1M | ||
| Q3 24 | $-3.2M | $-613.0K | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $11.7M | $-1.4M |
| Q4 25 | $10.1M | — | ||
| Q3 25 | $-1.3M | $25.0K | ||
| Q2 25 | $-24.4M | — | ||
| Q1 25 | $12.3M | $-4.3M | ||
| Q4 24 | $14.5M | $-8.6M | ||
| Q3 24 | $-3.3M | $-4.0M | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $11.7M | $-7.8M |
| Q4 25 | 43.0% | — | ||
| Q3 25 | -6.8% | 0.1% | ||
| Q2 25 | -90.4% | — | ||
| Q1 25 | 32.2% | -12.1% | ||
| Q4 24 | 46.1% | -26.3% | ||
| Q3 24 | -15.8% | -16.3% | ||
| Q2 24 | -5.6% | — | ||
| Q1 24 | 28.7% | -21.8% |
| Q4 25 | 4.1% | — | ||
| Q3 25 | 5.4% | 5.6% | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.4% | 15.5% | ||
| Q4 24 | 1.0% | 7.5% | ||
| Q3 24 | 0.4% | 13.9% | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 0.0% | 17.8% |
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | — | ||
| Q1 24 | 1.87× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GENC
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
